[Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
Garozzo
G
G
Granà
G
G
Lomeo
E
E
La Greca
M
M
Castiglione
M G
MG
Caruso
M
M
Curatolo
M
M
Gurgone
P
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
Impiego della timopentina nel trattamento del carcinoma ovarico: risultati clinici preliminari.